METHODS OF REDOSING GENE THERAPY VECTORS.

VE6142020000080SUndetermined Publication Date: 2022-02-17BIOMARIN PHARMACEUTICAL INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
VE · VE
Patent Type
Designs
Current Assignee / Owner
BIOMARIN PHARMACEUTICAL INC
Filing Date
2020-05-14
Publication Date
2022-02-17
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art

Description

This description refers, in general, to methods for readministering, or redosing, a subject who has undergone a first gene therapy regimen with a second or subsequent administration of a gene therapy regimen, wherein the first gene therapy vector and the second gene therapy vector comprise different AAV capsids but carry a transgene or polynucleotide useful for treating the same disease or disorder.